Vir Biotechnology, Inc. Common Stock

VIRNASDAQ • USD
ThemeBiotech - Drug Development›Infectious Disease & Vaccines
8.65 USD
↘ 0.50 (5.46%)AT CLOSE (11:59 AM EDT)
8.67
↗ 0.02 (0.23%)
POST MARKET (AS OF 07:27 PM EDT)
Post Market
AS OF 07:27 PM EDT
8.67
↗ 0.02 (0.23%)
🔴Market: CLOSED
Open?$9.09
High?$9.19
Low?$8.63
Prev. Close?$9.15
Volume?1.3M
Avg. Volume?1.6M
VWAP?$8.82
Rel. Volume?0.83x
Bid / Ask
Bid?$7.42 × 100
Ask?$9.95 × 100
Spread?$2.53
Midpoint?$8.68
Valuation & Ratios
Market Cap?1.5B
Shares Out?168.7M
Float?95.9M
Float %?68.7%
P/E Ratio?N/A
P/B Ratio?1.79
EPS?-$2.63
Dividend?0.00%
Ex-Dividend?N/A

VIR is currently priced at $8.65. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, VIR trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
Themes
Biotech - Drug Development›Infectious Disease & VaccinesHealthcare - Oncology›Targeted Therapy & Precision OncologyAI & Machine Learning›AI-Powered Analytics & Decision Systems
Employees
367
Market Cap
1.5B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.vir.bio
Listed
2019-10-11
Address
1800 OWENS STREET
SAN FRANCISCO, CA 94158
Phone: 415-906-4324
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
18
Momentum?
27
Short Sent.?
19
Piotroski F-Score?1/9Weak
Altman Z-Score?1.37Distress
Confidence?73%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?17.55%High
Short Interest?16.8M
Days to Cover?11.0
Free Float95.9M
Avg Daily Volume1.5M
Settlement Date2026-05-15
Financial Health
Current Ratio?7.08Strong
Quick Ratio?7.08Strong
Cash Ratio?3.73Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
80
1.79CHEAP▾
P/S?
Peers
100
S&P
3
22.27HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.6CHEAP▾
EV/Sales?
Peers
100
S&P
3
18.09HIGH▾
Returns & Efficiency
ROE?
S&P
3
-54.5%WEAK▾
ROA?
S&P
3
-43.2%WEAK▾
Cash Flow & Enterprise
FCF?$-449644000
Enterprise Value?$1.2B
Fundamentals ratios updated end of day
MarketsMoversWatchlist